ALS Clinical Trials in Chicago

Showing 61-79 of 79 trials

Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS

NCT00021697

The purpose of this study is to compare and evaluate the safety of AVP-923 (dextromethorphan/quinidine) for the treatment of emotional lability in ALS patients.

Amyotrophic Lateral Sclerosis

Avanir Pharmaceuticals100 participantsStarted Jan 2001

Loma Linda, California, United States • Los Angeles, California, United States • San Francisco, California, United States +14 more locations

COMPLETEDPhase 12.2 miles

Safety and Tolerability of Dalfampridine in Subjects With Cerebral Palsy

NCT01468350

A double-blind, placebo-controlled, crossover study in subjects with cerebral palsy (CP) to evaluate the safety and tolerability and the effect of dalfampridine extended release (ER) tablets on sensorimotor function

Cerebral Palsy (CP)

Acorda Therapeutics35 participantsStarted Dec 2011

Birmingham, Alabama, United States • Downey, California, United States • Los Angeles, California, United States +8 more locations

PreviousPage 4 of 4

Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS

Safety and Tolerability of Dalfampridine in Subjects With Cerebral Palsy

ALS Trials in Other Cities

Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy

Internet Intervention for the Prevention of Depression - Approaches to Improving Mood

A Multicenter, Double-Blind Study to Investigate the Safety and Efficacy of Arimoclomol in Volunteers With ALS

Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity

Minocycline to Treat Amyotrophic Lateral Sclerosis

Creatine for the Treatment of Amyotrophic Lateral Sclerosis

Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis

Clinical Trial Nuedexta in Subjects With ALS

Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy

Motor-Point Stimulation for Conditioning the Diaphragm of Patients With Amyotrophic Lateral Sclerosis (ALS)

Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation

Talampanel for Amyotrophic Lateral Sclerosis (ALS)

A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS

Study of Electrical Impedance Myography (EIM) in ALS

Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)

SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS)

Other Conditions in Chicago